--- title: "Edwards, The 'Cleanest Large-Cap Medtech Story,' Launches On Second-Quarter Beat" type: "News" locale: "en" url: "https://longbridge.com/en/news/293777588.md" description: "Shares of Edwards Lifesciences surged on Friday following the company's better-than-expected financial results, surpassing both revenue and profit projections set by Wall Street analysts. The medtech company is being hailed as the \"cleanest large-cap medtech story\" after its strong performance in the second quarter. The stock launch saw impressive gains, highlighting the positive reception from investors to the company's financial success." datetime: "2026-07-24T15:34:21.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293777588.md) - [en](https://longbridge.com/en/news/293777588.md) - [zh-HK](https://longbridge.com/zh-HK/news/293777588.md) generator: "portal-rs" --- # Edwards, The 'Cleanest Large-Cap Medtech Story,' Launches On Second-Quarter Beat Shares of Edwards Lifesciences surged on Friday following the company's better-than-expected financial results, surpassing both revenue and profit projections set by Wall Street analysts. The medtech company is being hailed as the "cleanest large-cap medtech story" after its strong performance in the second quarter. The stock launch saw impressive gains, highlighting the positive reception from investors to the company's financial success. ### Related Stocks - [EW.US](https://longbridge.com/en/quote/EW.US.md) ## Related News & Research - [Here’s How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 20 Years](https://longbridge.com/en/news/296380036.md) - [BOK Financial Private Wealth Inc. Acquires Shares of 12,115 Edwards Lifesciences Corporation $EW](https://longbridge.com/en/news/296316664.md) - [What Are Wall Street Analysts' Target Price for Agilent Technologies Stock?](https://longbridge.com/en/news/296517533.md) - [Edwards Lifesciences CVP TAVR Daniel J. Lippis melepas 619 saham senilai $ 56.966,57](https://longbridge.com/en/news/295581060.md) - [Handelsbanken Fonder AB Has $139.42 Million Holdings in Edwards Lifesciences Corporation $EW](https://longbridge.com/en/news/295520666.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**